Edition:
United Kingdom

Apricus Biosciences Inc (APRI.OQ)

APRI.OQ on NASDAQ Stock Exchange Capital Market

1.75USD
8 Dec 2017
Change (% chg)

$-0.02 (-1.13%)
Prev Close
$1.77
Open
$1.78
Day's High
$1.81
Day's Low
$1.73
Volume
13,901
Avg. Vol
39,057
52-wk High
$4.07
52-wk Low
$0.87

Select another date:

Thu, Nov 2 2017

BRIEF-Apricus Biosciences files for mixed shelf of up to $100 million

* Apricus Biosciences files for mixed shelf of up to $100 million - SEC filing Source text : (http://bit.ly/2gZ2TjB) Further company coverage:

BRIEF-Apricus Biosciences files for resale of up to 3.3 mln of common stock by selling stockholders

* Apricus Biosciences Inc files for resale of up to 3.3 million of common stock by selling stockholders - SEC Filing Source text :(http://bit.ly/2y3YztZ) Further company coverage:

BRIEF-Apricus Biosciences says Armistice Capital reports a 9.6 pct passive stake in co

* Armistice Capital LLC reports 9.6 percent passive stake in Apricus Biosciences Inc, as of September 10, 2017 - SEC filing ‍​ Source text: [http://bit.ly/2xgpiTr] Further company coverage:

BRIEF-Apricus Biosciences announces $3.7 million private placement priced at-the-market

* Apricus Biosciences announces $3.7 million private placement priced at-the-market

BRIEF-Apricus Biosciences announces FDA acknowledgement of Vitaros class 2 NDA resubmission

* Apricus Biosciences announces FDA acknowledgement of Vitaros class 2 NDA resubmission

BRIEF-Apricus Biosciences files NDA resubmission for Vitaros

* Apricus Biosciences Inc - Apricus anticipates a six-month review by FDA with a projected PDUFA goal date in Q1 of 2018 Source text for Eikon: Further company coverage:

BRIEF-Apricus Biosciences Q2 loss per share $0.13

* Apricus Biosciences provides corporate update and second quarter 2017 financial results

Select another date: